+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Coronary Stents Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • ID: 4620294
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Amaranth Medical, Inc.
  • B.Braun Melsungen AG
  • Biotronik SE & Co. KG
  • C.R. Bard, Inc.
  • Cook Medical, Inc.
  • MORE
Coronary Stents Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026, the global coronary stents market was valued at US$ 6,216.7 Mn in 2017, and is expected to reach US$ 11,622.5 Mn by 2026, expanding at a CAGR of 7.3% from 2018 to 2026.

Market Insights
Coronary artery disease develops in patients when the coronary artery which delivers blood, nutrients and oxygen to heart becomes damaged. The cholesterol containing plaques are deposited in the coronary artery over a period of time which results in inflammation. Repeated vascular cell wall inflammation coupled with atherosclerotic plaque deposition causes the formation of neointima hyperplasia at the site of vessel damage. There is eventually narrowing of the coronary artery which builds tremendous pressure on the heart eventually resulting in myocardial infarction or stroke. Coronary stents are employed for widening the artery at the site of blockade. In the last 2 decades there has been technological advancement in the manufacturing of stents to counteract complication such as restenosis and stent-in-stent procedure. The only limitation the coronary stents market face is the exorbitant price of drug eluting stents and competition exerted by percutaneous coronary intervention.

Drug eluting stents are currently dominating the coronary stents market on account of key factors such as rising prevalence of coronary artery stenosis, technological advancement in the formulation of biodegradable polymers containing antiproliferative agents to prevent restenosis. Drug eluting stents are completely overshadowing the bare metal stents due to the inherent qualities it possess such as surface smoothness, thinner struts and durable metal alloys. Bioresorbable vascular scaffolds are gaining prominence for the treatment of coronary artery diseases due to key factors such as ability to restore the normal vessel shape and function, eliminate vessel irritation and inflammation and excellent patient compliance.

In the present scenario North America dominates the regional segment for coronary stents market. As per the statistics presented by Center for Disease Control and Prevention (CDC) annually 370,000 U.S. citizens die due to coronary artery disease. The American Africans are at a higher risk for cardiovascular disease on account of their unhealthy lifestyle, tobacco smoking and rise in obesity. In Europe, the market growth is determined by the presence of key players such as Abbott Laboratories, Inc. and Medtronic, Plc. pioneering in manufacturing of coronary stents. Asia Pacific is set to register significant growth during the forecast period owing to the rising prevalence of cardiovascular ailment, rise in per capita income and growth in medical tourism.
The major players engaged in the manufacturing of coronary stents are Amaranth Medical, Inc., Abbott Laboratories, Inc., Boston Scientific Corporation, Cook Medical, Inc., B. Braun Melsungen AG, C.R. Bard, Inc., Biotronik SE & Co. KG, Medtronic Plc, Terumo Corporation and Microport Scientific Corporation.

Key Market Movements:
  • Rising prevalence of cardiovascular complications and obesity in developed nations
  • Growing public health awareness regarding heart ailments and adherence to effective treatment guidelines to drive market growth in developing nations
  • Technological advancement in stent development to minimize restenosis and improve patient compliance
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Amaranth Medical, Inc.
  • B.Braun Melsungen AG
  • Biotronik SE & Co. KG
  • C.R. Bard, Inc.
  • Cook Medical, Inc.
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Coronary Stents Market Portraiture
2.2. Global Coronary Stents Market, by Product, 2017 (US$ Mn)
2.3. Global Coronary Stents Market, by Geography, 2017 (US$ Mn)

Chapter 3. Coronary Stents Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Coronary Stents Market, by Key Players, 2017

Chapter 4. Global Coronary Stents Market, by Product
4.1. Overview
4.2. Drug Eluting Stent
4.3. Bare Metal Stent
4.4. Bioresorbable Vascular Scaffolds

Chapter 5. Global Coronary Stents Market, by Geography
5.1. Overview
5.2. North America Coronary Stents Market Analysis, 2016 – 2026
5.2.1. North America Coronary Stents Market, by Product, 2016 – 2026 (US$ Mn)
5.2.2. North America Coronary Stents Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Coronary Stents Market Analysis, 2016 – 2026
5.3.1. Europe Coronary Stents Market, by Product, 2016 – 2026 (US$ Mn)
5.3.2. Europe Coronary Stents Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Coronary Stents Market Analysis, 2016 – 2026
5.4.1. Asia Pacific Coronary Stents Market, by Product, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific Coronary Stents Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America Coronary Stents Market Analysis, 2016 – 2026
5.5.1. Latin America Coronary Stents Market, by Product, 2016 – 2026 (US$ Mn)
5.5.2. Latin America Coronary Stents Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa Coronary Stents Market Analysis, 2016 – 2026
5.6.1. MEA Coronary Stents Market, by Product, 2016 – 2026 (US$ Mn)
5.6.2. MEA Coronary Stents Market, by Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. Amaranth Medical, Inc.
6.3. Biotronik SE & Co. KG
6.4. B.Braun Melsungen AG
6.5. Boston Scientific Corporation
6.6. Cook Medical, Inc.
6.7. C.R. Bard, Inc.
6.8. Johnson & Johnson
6.9. Medtronic, Plc
6.10. Microport Scientific Corporation
6.11. Terumo Corporation

List of Figures:
Figure. 1 Coronary Stents Market: Research Methodology
Figure. 2 Coronary Stents: Market Segmentation
Figure. 3 Global Coronary Stents Market, by Product, 2017 (US$ Mn)
Figure. 4 Global Coronary Stents Market, by Geography, 2017 (US$ Mn)
Figure. 5 Attractive Investment Proposition: by Geography, 2017
Figure. 6 Competitive Analysis: Global Coronary Stents Market, by Key Players, 2017
Figure. 7 Global Drug Eluting Stents Market, 2016 – 2026 (US$ Mn)
Figure. 8 Global Bare Metal Stents Market, 2016 – 2026 (US$ Mn)
Figure. 9 Global Bioresorbable Vascular Scaffolds Market, 2016 – 2026 (US$ Mn)
Figure. 10 U.S. Coronary Stents Market, 2016 – 2026 (US$ Mn)
Figure. 11 Canada Coronary Stents Market, 2016 – 2026 (US$ Mn)
Figure. 12 U.K. Coronary Stents Market, 2016 – 2026 (US$ Mn)
Figure. 13 Germany Coronary Stents Market, 2016 – 2026 (US$ Mn)
Figure. 14 Rest of Europe Coronary Stents Market, 2016 – 2026 (US$ Mn)
Figure. 15 China Coronary Stents Market, 2016 – 2026 (US$ Mn)
Figure. 16 Japan Coronary Stents Market, 2016 – 2026 (US$ Mn)
Figure. 17 Rest of Asia Pacific Coronary Stents Market, 2016 – 2026 (US$ Mn)
Figure. 18 Brazil Coronary Stents Market, 2016 – 2026 (US$ Mn)
Figure. 19 Mexico Coronary Stents Market, 2016 – 2026 (US$ Mn)
Figure. 20 Rest of Latin America Coronary Stents Market, 2016 – 2026 (US$ Mn)
Figure. 21 GCC Coronary Stents Market, 2016 – 2026 (US$ Mn)
Figure. 22 Rest of Middle East and Africa Coronary Stents Market, 2016 – 2026 (US$ Mn)

List of Tables:
Table 1 Global Coronary Stents Market Portraiture
Table 2 Global Coronary Stents Market, by Product, 2016 – 2026 (US$ Mn)
Table 3 Global Coronary Stents Market, by Geography, 2016 – 2026 (US$ Mn)
Table 4 North America Coronary Stents Market, by Product, 2016 – 2026 (US$ Mn)
Table 5 North America Coronary Stents Market, by Country, 2016 – 2026 (US$ Mn)
Table 6 Europe Coronary Stents Market, by Product, 2016 – 2026 (US$ Mn)
Table 7 Europe Coronary Stents Market, by Country/Region, 2016 – 2026 (US$ Mn)
Table 8 Asia Pacific Coronary Stents Market, by Product, 2016 – 2026 (US$ Mn)
Table 9 Asia Pacific Coronary Stents Market, by Country/Region, 2015 – 2025 (US$ Mn)
Table 10 Latin America Coronary Stents Market, by Product, 2016 – 2026 (US$ Mn)
Table 11 Latin America Coronary Stents Market, by Country/Region, 2016 – 2026 (US$ Mn)
Table 12 Middle East and Africa Coronary Stents Market, by Product, 2016 – 2026 (US$ Mn)
Table 13 Middle East and Africa Coronary Stents Market, by Region, 2016 – 2026 (US$ Mn)
Table 14 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 15 Amaranth Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 16 Biotronik SE & Co. KG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 17 B.Braun Melsungen AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 18 Boston Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 19 Cook Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 20 C.R. Bard, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 21 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 22 Medtronic, Plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 23 Microport Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 24 Terumo Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories, Inc.
  • Amaranth Medical, Inc.
  • Biotronik SE & Co. KG
  • B.Braun Melsungen AG
  • Boston Scientific Corporation
  • Cook Medical, Inc.
  • C.R. Bard, Inc.
  • Johnson & Johnson
  • Medtronic, Plc
  • Microport Scientific Corporation
  • Terumo Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4620294
Adroll
adroll